🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Thomas J. Baric

University of North Carolina at Chapel Hill

ORCID: 0009-0005-8682-0740
Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “The oral nucleoside prodrug GS-5245 is efficacious against SARS-CoV-2 and other endemic, epidemic, and enzootic coronaviruses”.

The oral nucleoside prodrug GS-5245 is efficacious against SARS-CoV-2 and other endemic, epidemic, and enzootic coronaviruses

Science Translational Medicine(2024)10.1126/scitranslmed.adj4504
N/A
0.888DataRank · unranked
22 citations

Fernando R. Moreira, Nicholas Catanzaro, Meghan V. Diefenbacher, Mark R. Zweigart, Kendra L. Gully +27 more

An oral non-covalent non-peptidic inhibitor of SARS-CoV-2 Mpro ameliorates viral replication and pathogenesis in vivo

Cell Reports(2024)10.1016/j.celrep.2024.114929
N/A
0.398DataRank · unranked
10 citations

Su Tang, Xuelin Bian, Maloy Kumar Parai, Inna V. Krieger, Armando Flores +27 more

A live dengue virus vaccine carrying a chimeric envelope glycoprotein elicits dual DENV2-DENV4 serotype-specific immunity

Nature Communications(2023)10.1038/s41467-023-36702-x
N/A
0DataRank · unranked
18 citations

Boyd L. Yount, Petraleigh Pantoja, Sandra Henein, Rita M. Meganck, Jennifer McBride +14 more

Efficacy of the oral nucleoside prodrug GS-5245 (Obeldesivir) against SARS-CoV-2 and coronaviruses with pandemic potential

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.06.27.546784
N/A
0DataRank · unranked
12 citations

Fernando R. Moreira, Mark R. Zweigart, Kendra L. Gully, Gabriela De la Cruz, Ariane J. Brown +25 more

Animal Models, Therapeutics, and Vaccine Approaches to Emerging and Re-Emerging Flaviviruses

Viruses(2024)10.3390/v17010001
N/A
0DataRank · unranked
7 citations

Z. Beau Reneer, Thomas J. Baric

An oral non-covalent non-peptidic inhibitor of SARS-CoV-2 Mpro ameliorates viral replication and pathogenesis in vivo

UNC Libraries(2024)10.17615/wwq1-b853
N/A
0DataRank · unranked
0 citations

Maloy Kumar Parai, Timothy P. Sheahan, Jeremy P. Wood, Bian, Xuelin, Inna V. Krieger +27 more

Identification of Dengue Virus Serotype 3 Specific Antigenic Sites Targeted by Neutralizing Human Antibodies

Cell Host & Microbe(2020)10.1016/j.chom.2020.04.007
N/A
0DataRank · unranked
48 citations

Robert H. Carnahan, Daniela V. Andrade, Nurgun Kose, Rachel S. Nargi, Ethan J. Fritch +22 more

Animal Models, Therapeutics, and Vaccine Approaches to Emerging and Re-Emerging Flaviviruses

UNC Libraries(2025)10.17615/05af-5063
N/A
0DataRank · unranked
0 citations

Thomas J. Baric, Z. Beau Reneer

Genetic Variation between Dengue Virus Type 4 Strains Impacts Human Antibody Binding and Neutralization

UNC Libraries(2020)10.17615/4ntf-3q10
N/A
0DataRank · unranked
0 citations

Anna P. Durbin, Usha K. Nivarthi, Douglas G. Widman, Rachel L. Graham, Thomas J. Baric +6 more